Companies and Markets - Page 1

GlaxoSmithKline to expand Melbourne site
Wednesday, February 08, 2012 UK-based pharmaceutical major GlaxoSmithKline (GSK) has announced plans to invest A$60m to expand its manufacturing and drug development activities at its Boronia facility near Melbourne,...

UK Health Ministers “in denial” over drug shortages, says AAH
Tuesday, February 07, 2012 A UK health minister has been criticised for his remarks regarding the "inevitable" drug shortages in the...

Merck Serono licenses Threshold cancer drug
Monday, February 06, 2012 Merck Serono, a unit of German pharmaceutical manufacturer Merck, has signed a licensing agreement with US-based biotechnology firm Threshold Pharmaceuticals for the development...

Taiwan vaccine manufacturer to be listed on stock exchange
Monday, February 06, 2012 Adimmune Corp, a vaccine manufacturer based in Taiwan, could be list on the stock market in March at the earliest, the company announced...

Merck receives FDA approval for Janumet
Friday, February 03, 2012 US-based pharmaceutical company Merck has received US Food and Drug Administration (FDA) approval for Janumet XR, its new type 2 diabetes...

AstraZeneca job cuts more severe than feared
Thursday, February 02, 2012 Job cuts at Anglo-Swedish pharmaceutical firm AstraZeneca (AZ) are to be worse than feared, following an announcement made by the company amid rumours previously reported in the Sunday...

Generic Liptor causes Pfizer profit slump
Thursday, February 02, 2012 Pharmaceutical major Pfizer has announced a 50% slump in net income for Q4 2011 as the company suffers at the hands of generic versions of its cholesterol blockbuster...

Reports fuel rumours of further job cuts at AstraZeneca
Wednesday, February 01, 2012 AstraZeneca is rumoured to be cutting up to 3,000 further jobs ahead of posting its full-year financial results, reports published in the Sunday Times...

Big Pharma to collaborate to combat neglected diseases
Monday, January 30, 2012 Some of the world’s largest pharmaceutical companies are joining forces with health organisations to donate drugs aimed at controlling or eradicating ten neglected tropical diseases by...

Amgen to acquire Micromet
Monday, January 30, 2012 US-based pharmaceutical firm Amgen is to acquire the Germany-based biotechnology company Micromet in a deal that values the company at approximately...

Xenoport accuses GSK of contract breach
Friday, January 27, 2012 US-based Xenoport has accused UK-based pharmaceutical major GlaxoSmithKline (GSK) of a breach of contract and is threatening to end the pact relating to restless legs syndrome medication...

Novartis net profit falls 47%
Thursday, January 26, 2012 Novartis has reported that its fourth quarter net profit fell 47% to $1.21bn as the company felt the impact of a previously disclosed charge of $900m, relating to a forecasted decline for sales...

Hikma and Ergomed announce clinical trial partnership
Thursday, January 26, 2012 Hikma Pharmaceuticals has partnered with Ergomed in order for the latter to manage clinical trials involving Hikma...

Novo Nordisk to establish US diabetes research centre
Wednesday, January 25, 2012 Denmark-based pharmaceutical company Novo Nordisk is to create a research and development centre in Seattle, US, for type 1 diabetes, in order to further research into a disease that the...

Roche hostile bid for Illumina deemed “full and fair”
Wednesday, January 25, 2012 Switzerland-based drugmaker Roche has described its $5.7bn hostile offer for US gene sequencing company Illumina as “full and fair”, confirming that it does not plan to increase its...

Watson to acquire Ascent Pharmahealth
Tuesday, January 24, 2012 US-based Watson Pharmaceuticals has acquired Strides Arcolab subsidiary Ascent Pharmahealth in a deal worth A$375m...

BTG receives US Voraxaze approval
Friday, January 20, 2012 UK-based pharmaceutical company BTG has received US Food and Drug Adminsitration (FDA) approval for its Voraxaze medication, which is used to treat patients suffering from toxic levels...

Jobs lost as Takeda restructures
Thursday, January 19, 2012 Restructuring at Japan-headquartered Takeda Pharmaceuticals is to result in the loss of 2,800 jobs, with European-based positions likely to be the hardest...

Singapore sees rise in pharmaceutical shipments
Wednesday, January 18, 2012 A rise in pharmaceutical shipments to Europe led to an unexpected lift in Singapore’s non-oil exports last month, trade promotion agency International Enterprise Singapore has...

Novartis to cut nearly 2,000 US pharma jobs
Tuesday, January 17, 2012 Novartis will cut nearly 2,000 jobs in the US ahead of the patent expiration of its Diovan (valsartan) drug and an expected reduction in demand for Rasilez / Tekturna (aliskiren) following...